AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
Quick Stats
Jan 30, 202660.6
AI Score
BUY1.18
Volume Ratio
Feb 04, 2026
Next Earnings
17
+ve Days (30d)
13
-ve Days (30d)
ABBV Stock Summary
Last updated Jan 30, 2026
ABBV is currently trading at $223.01, positioned above its 200-day moving average of $208.4, indicating a long-term uptrend. The stock has a 52-week range of $164.39 to $244.81.
Technical Analysis: The 50-day moving average stands at $224.99, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 50.642, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.124, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates ABBV at 60.6/100 with a BUY recommendation.
ABBV (ABBVIE INC.) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 50.642 |
| CMF (20) | 0.124 |
| ROC (10) | 2.641 |
| ADX (14) | 9.022 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -1.297 |
| AROONOSC (14) | 35.714 |
| WILLAMS %R (14) | -25.947 |
| MFI (14) | 57.541 |
ABBV Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
ABBV Price vs Max Options Open Interest
ABBV Max Change In Options Open Interest
ABBV Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ABBV Daily Out of Money Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ABBV Daily In the Money Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ABBV Most Active Options by Volume(near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ABBVIE INC. is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
ABBV Moving Averages Analysis
ABBVIE INC. has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jan 30, 2026
ABBV (ABBVIE INC.) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 218.89 |
| 20 | 220.97 |
| 30 | 223.36 |
| 50 | 224.99 |
| 100 | 225.15 |
| 200 | 208.4 |
ABBV Fundamental Analysis
| P/E (Forward) | 15.5763 |
| P/E (Trailing) | 166.9237 |
| Market Cap ($) | 386.5 billion |
| Earnings/Share ($) | 1.31 |
| Net Proft Margin (%) | 0.04 |
| Dividend/Share ($) | 6.56 |
| EPS Estimate Current Year ($) | 9.8943 |
| EPS Estimate Next Year ($) | 14.2412 |
| WallStreet Target Price ($) | 245.037 |
| Most Recent Quarter |